Debt-to-equity of Dermata Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Dermata Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
Dermata Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 37%, a 1.8% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Dermata Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	37%	-1%	-1.8%	30 Sep 2025
Q2 2025	40%	+10%	+36%	30 Jun 2025
Q1 2025	50%	+32%	+170%	31 Mar 2025
Q4 2024	54%	+38%	+250%	31 Dec 2024
Q3 2024	38%	+25%	+188%	30 Sep 2024
Q2 2024	29%	+15%	+101%	30 Jun 2024
Q1 2024	19%	+3%	+17%	31 Mar 2024
Q4 2023	15%	-1%	-4.6%	31 Dec 2023
Q3 2023	13%	-3%	-18%	30 Sep 2023
Q2 2023	15%	+1%	+11%	30 Jun 2023
Q1 2023	16%	-3%	-14%	31 Mar 2023
Q4 2022	16%			31 Dec 2022
Q3 2022	16%			30 Sep 2022
Q2 2022	13%			30 Jun 2022
Q1 2022	19%			31 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.